Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Fluoxetine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for fluoxetine hydrochloride and what is the scope of fluoxetine hydrochloride freedom to operate?

Fluoxetine hydrochloride
is the generic ingredient in eight branded drugs marketed by Teva Pharms Usa, Lilly, Barr, Teva, Dr Reddys Labs Inc, Mylan, Sandoz, Aurobindo Pharma Ltd, Wockhardt, Pharm Assoc, Aurobindo Pharma, Mallinckrodt, Carlsbad, Par Pharm, Alembic Pharms Ltd, Hi Tech Pharma, Alvogen, Heritage Pharms Inc, Eli Lilly And Co, Par Form, Torrent Pharms Ltd, Wockhardt Ltd, Ivax Sub Teva Pharms, Silarx, Lannett, Apil, Watson Labs, Landela Pharm, Cr Double Crane, Dr Reddys Labs Ltd, Mylan Pharms Inc, Sun Pharm Inds, Ani Pharms Inc, Sun Pharm Inds Ltd, Actavis Mid Atlantic, Apotex Inc, Sciegen Pharms Inc, and Teva Pharms, and is included in fifty-nine NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Fluoxetine hydrochloride has eighty-three patent family members in fifty-one countries.

There are twenty-seven drug master file entries for fluoxetine hydrochloride. Seventy-one suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: fluoxetine hydrochloride

Drug Master File Entries: see list27
Suppliers / Packagers: see list71
Bulk Api Vendors: see list83
Clinical Trials: see list1,051
Patent Applications: see list4,982
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fluoxetine hydrochloride at DailyMed

Pharmacology for Ingredient: fluoxetine hydrochloride

Tentative approvals for FLUOXETINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 10MG BASECAPSULE;ORAL
► Subscribe► SubscribeEQ 40MG BASECAPSULE;ORAL
► Subscribe► SubscribeEQ 20MG BASECAPSULE;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cr Double Crane
fluoxetine hydrochloride
CAPSULE;ORAL076165-001Feb 1, 2002DISCNNoNo► Subscribe► Subscribe
Sun Pharm Inds
fluoxetine hydrochloride
CAPSULE;ORAL075787-002Jan 29, 2002DISCNNoNo► Subscribe► Subscribe
fluoxetine hydrochloride; olanzapine
CAPSULE;ORAL078901-001Nov 16, 2012ABRXNoNo► Subscribe► Subscribe
Alembic Pharms Ltd
fluoxetine hydrochloride
TABLET;ORAL208698-002Apr 5, 2017ABRXNoNo► Subscribe► Subscribe
fluoxetine hydrochloride
CAPSULE;ORAL075807-002Jan 29, 2002DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus